Registro:

Referencias:

• Shumaker, S.A., Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study (2003) J. Am. Med. Assoc., 289, pp. 2651-2662
• Pike, C.J., Protective actions of sex steroid hormones in Alzheimer's disease (2009) Front. Neuroendocrinol., 30, pp. 239-258
• Bourque, M., Neuroprotective actions of sex steroids in Parkinson's disease (2009) Front. Neuroendocrinol., 30, pp. 142-157
• Suzuki, S., Neuroprotective effects of estrogens following ischemic stroke (2009) Front. Neuroendocrinol., 30, pp. 201-211
• Etgen, A.M., Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: Translational implications (2011) Front. Neuroendocrinol., 32, pp. 336-352
• Kipp, M., Beyer, C., Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis (2009) Front. Neuroendocrinol., 30, pp. 188-200
• Pietranera, L., Involvement of brain-derived neurotrophic factor and neurogenesis in oestradiol neuroprotection of the hippocampus of hypertensive rats (2010) J. Neuroendocrinol., 22, pp. 1082-1092
• Barreto, G., Selective estrogen receptor modulators decrease astrogliosis in the injured brain: effects of aging and prolonged depletion of ovarian hormones (2009) Endocrinology, 150, pp. 5010-5015
• Saraceno, G.E., Estradiol therapy in adulthood reverses glial and neuronal alterations caused by perinatal asphyxia (2010) Exp. Neurol., 223, pp. 615-622
• Tiwari-Woodruff, S., Voskuhl, R.R., Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice (2009) J. Neurol. Sci., 286, pp. 81-85
• Jover-Mengual, T., MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia (2007) Endocrinology, 148, pp. 1131-1143
• Yang, L.C., Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus (2010) PLoS ONE, 5, pp. e9851
• Gingerich, S., Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17beta-estradiol in novel murine hippocampal cell models (2010) Neuroscience, 170, pp. 54-66
• Lebesgue, D., Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats (2010) PLoS ONE, 5, pp. e8642
• Ruiz-Palmero, I., Notch/Neurogenin 3 signalling is involved in the neuritogenic actions of oestradiol in developing hippocampal neurones (2011) J. Neuroendocrinol., 23, pp. 355-364
• Gorosito, S.V., Estrogen receptor alpha is expressed on the cell-surface of embryonic hypothalamic neurons (2008) Neuroscience, 154, pp. 1173-1177
• Dominguez, R., Micevych, P., Estradiol rapidly regulates membrane estrogen receptor alpha levels in hypothalamic neurons (2010) J. Neurosci., 30, pp. 12589-12596
• Marin, R., Role of estrogen receptor alpha in membrane-initiated signaling in neural cells: interaction with IGF-1 receptor (2009) J. Steroid Biochem. Mol. Biol., 114, pp. 2-7
• Herrera, J.L., Estradiol and tamoxifen differentially regulate a plasmalemmal voltage-dependent anion channel involved in amyloid-beta induced neurotoxicity (2011) Steroids, 76, pp. 840-844
• Ramírez, C.M., VDAC and ERalpha interaction in caveolae from human cortex is altered in Alzheimer's disease (2009) Mol. Cell. Neurosci., 42, pp. 172-183
• Garcia-Segura, L.M., Interactions of estradiol and insulin-like growth factor-I signalling in the nervous system: new advances (2010) Prog. Brain Res., 181, pp. 251-272
• Alonso, A., Chronic estradiol treatment improves brain homeostasis during aging in female rats (2008) Endocrinology, 149, pp. 57-72
• Varea, O., Interaction of estrogen receptors with insulin-like growth factor-I and Wnt signaling in the nervous system (2010) Steroids, 75, pp. 565-569
• Selvamani, A., Sohrabji, F., The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1 (2010) J. Neurosci., 30, pp. 6852-6861
• Quesada, A., PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease (2008) Dev. Neurobiol., 68, pp. 632-644
• Lebesgue, D., Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection (2009) Steroids, 74, pp. 555-561
• Zhang, Q.G., Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation (2008) J. Neurosci., 28, pp. 8430-8441
• Peri, A., New insights on the neuroprotective role of sterols and sex steroids: the seladin-1/DHCR24 paradigm (2009) Front. Neuroendocrinol., 30, pp. 119-129
• De Marinis, E., 17β-Estradiol - a new modulator of neuroglobin levels in neurons: role in neuroprotection against H 2O 2-induced toxicity (2011) Neurosignals, 18, pp. 223-235
• Simpkins, J.W., Mitochondrial mechanisms of estrogen neuroprotection (2010) Biochim. Biophys. Acta, 1800, pp. 1113-1120
• Arevalo, M.A., Actions of estrogens on glial cells: implications for neuroprotection (2010) Biochim. Biophys. Acta, 1800, pp. 1106-1112
• Taylor, L.C., 17beta-Estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss (2010) Neurobiol. Dis., 39, pp. 127-137
• Carbonaro, V., Enhanced expression of ERalpha in astrocytes modifies the response of cortical neurons to beta-amyloid toxicity (2009) Neurobiol. Dis., 33, pp. 415-421
• Azcoitia, I., Role of astroglia in the neuroplastic and neuroprotective actions of estradiol (2010) Eur. J. Neurosci., 32, pp. 1995-2002
• Giraud, S.N., Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes (2010) Proc. Natl. Acad. Sci. U.S.A., 107, pp. 8416-8421
• Spence, R.D., Neuroprotection mediated through estrogen receptor α in astrocytes (2011) Proc. Natl. Acad. Sci. U.S.A., 108, pp. 8867-8872
• López Rodríguez, A.B., Estradiol decreases cortical reactive astrogliosis after brain injury by a mechanism involving cannabinoid receptors (2011) Cereb. Cortex, 21, pp. 2046-2055
• Crawford, D.K., Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination (2010) Brain, 133, pp. 2999-3016
• Du, S., Estrogen receptor-β ligand treatment modulates dendritic cells in the target organ during autoimmune demyelinating disease (2011) Eur. J. Immunol., 41, pp. 140-150
• Hirahara, Y., The localization and non-genomic function of the membrane-associated estrogen receptor in oligodendrocytes (2009) Glia, 57, pp. 153-165
• Azcoitia, I., Estradiol synthesis within the human brain (2011) Neuroscience, 191, pp. 139-147
• Remage-Healey, L., Brain estrogens rapidly strengthen auditory encoding and guide song preference in a songbird (2010) Proc. Natl. Acad. Sci. U.S.A., 107, pp. 3852-3857
• Zhou, L., Aromatase inhibitors induce spine synapse loss in the hippocampus of ovariectomized mice (2010) Endocrinology, 151, pp. 1153-1160
• Charlier, T.D., Diversity of mechanisms involved in aromatase regulation and estrogen action in the brain (2010) Biochim. Biophys. Acta, 1800, pp. 1094-1105
• Gatson, J.W., Aromatase is increased in astrocytes in the presence of elevated pressure (2011) Endocrinology, 152, pp. 207-213
• Saldanha, C.J., Neuroprotective actions of brain aromatase (2009) Front. Neuroendocrinol., 30, pp. 106-118
• Garcia-Segura, L.M., Aromatase in the brain: not just for reproduction anymore (2008) J. Neuroendocrinol., 20, pp. 705-712
• Pietranera, L., Increased aromatase expression in the hippocampus of spontaneously hypertensive rats: effects of estradiol administration (2011) Neuroscience, 174, pp. 151-159
• De Nicola, A.F., Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration (2009) Front. Neuroendocrinol., 30, pp. 173-187
• Stein, D.G., Wright, D.W., Progesterone in the clinical treatment of acute traumatic brain injury (2010) Expert. Opin. Invest. Drugs, 19, pp. 847-857
• Frye, C.A., Walf, A., Progesterone, administered before kainic acid, prevents decrements in cognitive performance in the Morris Water Maze (2011) Dev. Neurobiol., 71, pp. 142-152
• Moralí, G., Neuroprotective effects of progesterone and allopregnanolone on long-term cognitive outcome after global cerebral ischemia (2011) Restor. Neurol. Neurosci., 29, pp. 1-15
• Ciriza, I., Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective (2006) J. Neurobiol., 66, pp. 916-928
• Irwin, R.W., Medroxyprogesterone acetate antagonizes estrogen up-regulation of brain mitochondrial function (2011) Endocrinology, 152, pp. 556-567
• Morissette, M., Estrogen and SERM neuroprotection in animal models of Parkinson's disease (2008) Mol. Cell. Endocrinol., 290, pp. 60-69
• Acs, P., 17beta-Estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice (2009) Glia, 57, pp. 807-814
• Dang, J., Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats (2011) Brain Behav. Immun., 25, pp. 715-726
• Lima, F.B., Bethea, C.L., Ovarian steroids decrease DNA fragmentation in the serotonin neurons of non-injured rhesus macaques (2010) Mol. Psychiatry, 15, pp. 657-668
• Carroll, J.C., Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3× transgenic-Alzheimer's disease mice (2010) Endocrinology, 151, pp. 2713-2722
• Maki, P.M., Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life (2011) Brain Res., 1379, pp. 232-243
• Rocca, W.A., Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity (2011) Brain Res., 1379, pp. 188-198
• Hogervorst, E., Bandelow, S., Sex steroids to maintain cognitive function in women after the menopause: a meta-analyses of treatment trials (2010) Maturitas, 66, pp. 56-71
• Suzuki, S., Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions (2007) Proc. Natl. Acad. Sci. U.S.A., 104, pp. 6013-6018
• Hamilton, R.T., Hippocampal responsiveness to 17β-estradiol and equol after long-term ovariectomy: Implication for a therapeutic window of opportunity (2011) Brain Res., 1379, pp. 11-22
• Selvamani, A., Sohrabji, F., Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats (2010) Neurobiol. Aging, 31, pp. 1618-1628
• Strom, J.O., Different methods for administering 17beta-estradiol to ovariectomized rats result in opposite effects on ischemic brain damage (2010) BMC Neurosci., 11, p. 39
• Arevalo, M.A., Selective estrogen receptor modulators as brain therapeutic agents (2011) J. Mol. Endocrinol., 46, pp. R1-R9
• Lagunas, N., Estrogen receptor ligands counteract cognitive deficits caused by androgen deprivation in male rats (2011) Horm. Behav., 59, pp. 581-584
• Walf, A.A., Frye, C.A., Raloxifene and/or estradiol decrease anxiety-like and depressive-like behavior, whereas only estradiol increases carcinogen-induced tumorigenesis and uterine proliferation among ovariectomized rats (2010) Behav. Pharmacol., 21, pp. 231-240
• Espeland, M.A., Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition (2010) J. Womens Health (Larchmt.), 19, pp. 371-379
• Picazo, O., Neuroprotective actions of the synthetic estrogen 17alpha-ethynylestradiol in the hippocampus (2010) Cell. Mol. Neurobiol., 30, pp. 675-682
• Yi, K.D., The assessment of non-feminizing estrogens for use in neuroprotection (2011) Brain Res., 1379, pp. 61-70

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------